Nautilus Biotechnology In...
1.96
0.10 (5.38%)
At close: Jan 15, 2025, 3:59 PM
1.94
-1.02%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -5.87 -3.52 -8.7 -20.81 -7.80K 0.12
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 1.41 0.71 1.20 -10.94 4.16 15.01
P/FCF Ratio -6.9 -4.66 -10.54 -21.79 -7.09 -0.31
P/OCF Ratio -7.22 -4.9 -11.15 -23.23 -7.77 -0.31
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.13 0.10 0.08 -0.16 15.23 1.00
Quick Ratio 19.39 27.57 60.09 25.73 34.62 266.45
Current Ratio 19.39 27.57 60.09 25.73 34.62 266.45
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -10.94 n/a n/a n/a n/a
Return on Equity (ROE) -0.24 -0.2 -0.14 0.53 -0.00 125.32
Return on Assets (ROA) -0.21 -0.18 -0.13 -0.18 -0.00 4.30
Return on Capital (ROIC) -0.26 -0.19 -0.13 -0.19 -0.00 -0.77
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a